Our new state-of-the-art facility will allow for larger capacities to supply our customers with clinical batches for phase III clinical trials and small-scale for commercial.
The inauguration of our new production site dedicated to the manufacture of drug products took place on Friday 3 February. The company gathered 250 guests to celebrate this milestone for the company.
Liquid and lyophilised forms production line
CARBOGEN AMCIS expands capacity for parenteral drug manufacturing.
Le Point, September 2021
Article in French about the expansion in France and the new site Riom 2.
CARGOGEN AMCIS is expanding in France and the work is continuing!
Watch full CARBOGEN AMCIS presentation at the Virtual DCAT Member Company Announcement Forum.
La Montagne, May 2021
Article in French about the expansation Riom 2 of the second production plant for injectable anticancer drugs.
France Bleu, Apr 2021
Article in French about the expansion of Riom 2 in Saint-Beauzire (Puy-de-Dôme).
La Montagne, Apr 2021
Article in French about the expansion of Riom 2 in Saint-Beauzire (Puy-de-Dôme).
CARGOGEN AMCIS is expanding in France and the work has begun!
Vice President Alan Fischer & Vice President Stephan Fritschi on Radio SRF1.
Aargauer Zeitung, Mar 2021
Article in German about the progressing planning process for the expansion of the site in Hunzenschwil with an interview of Volker Wolfart.
Aargauer Zeitung, Mar 2021
Article in German about the update of the construction in Hunzenschwil, Switzerland.
Inauguration ceremony of construction works, 12. Jan 2021
Aargauer Zeitung, Oct 2020
Article in German about CARBOGEN AMCIS' investment in Hunzenschwil, Switzerland.
Chemical & Engineering News - Aug 2020
Article about CARBOGEN AMCIS' expansion in France and Switzerland.